Residential instability in a psychiatric emergency setting

1984 ◽  
Vol 56 (1) ◽  
pp. 20-34 ◽  
Author(s):  
Linda Chafetz ◽  
Stephen M. Goldfinger
Keyword(s):  
Psychiatric Emergency ◽  
Emergency Setting ◽  
Residential Instability

CHILDREN AND ADOLESCENTS IN THE PSYCHIATRIC EMERGENCY SETTING

1999 ◽  
Vol 22 (4) ◽  
pp. 865-874 ◽  
Author(s):  
Phill V. Halamandaris ◽  
Tanya Royster Anderson
Keyword(s):  
Children And Adolescents ◽  
Psychiatric Emergency ◽  
Emergency Setting

scholarly journals Issues related to testing for COVID-19 in a psychiatric emergency setting

2020 ◽  
Vol 54 ◽  
pp. 102338
Author(s):  
Kamaldeep Sadh ◽  
Bhaskaran A.S. ◽  
Tshering Lhamu ◽  
Chethan Basavarajappa ◽  
Ajit Dahale ◽  
...  
Keyword(s):  
Psychiatric Emergency ◽  
Emergency Setting

Characteristics associated with synthetic cannabinoid use among patients treated in a public psychiatric emergency setting

2016 ◽  
Vol 43 (1) ◽  
pp. 117-122 ◽  
Author(s):  
Adriana M. Joseph ◽  
Marc W. Manseau ◽  
Monique Lalane ◽  
Amit Rajparia ◽  
Crystal Fuller Lewis
Keyword(s):  
Synthetic Cannabinoid ◽  
Psychiatric Emergency ◽  
Emergency Setting

The psychometric properties of the Life History of Aggression evaluated in patients from a psychiatric emergency setting

2017 ◽  
Vol 257 ◽  
pp. 485-489
Author(s):  
Laura Dellazizzo ◽  
Stéphane Potvin ◽  
Charles-Édouard Giguère ◽  
Marieke Berwald ◽  
Jules R. Dugré ◽  
...  
Keyword(s):  
Life History ◽  
Psychometric Properties ◽  
Psychiatric Emergency ◽  
Emergency Setting ◽  
History Of

scholarly journals Screening for post-traumatic stress disorder (PTSD) in a psychiatric emergency setting

2012 ◽  
Vol 26 (3) ◽  
pp. 159-168 ◽  
Author(s):  
Marie-Laure Ivanov ◽  
Orest Weber ◽  
Mehdi Gholam-Rezaee ◽  
Gerrit Weber ◽  
Daphné Reeves ◽  
...  
Keyword(s):  
Post Traumatic Stress Disorder ◽  
Traumatic Stress ◽  
Stress Disorder ◽  
Psychiatric Emergency ◽  
Emergency Setting ◽  
Post Traumatic Stress ◽  
Post Traumatic

The Role of Diagnosis in a Psychiatric Emergency Setting

1984 ◽  
Vol 35 (7) ◽  
pp. 715-718
Author(s):  
Radwan Khuri ◽  
Keith Wood
Keyword(s):  
Psychiatric Emergency ◽  
Emergency Setting

Revisiting lorazepam challenge test: Clinical response with dose variations and utility for catatonia in a psychiatric emergency setting

2020 ◽  
pp. 000486742096891
Author(s):  
Hari Hara Suchandra ◽  
Venkata Senthil Kumar Reddi ◽  
Bhaskaran Aandi Subramaniyam ◽  
Krishna Prasad Muliyala
Keyword(s):  
Rating Scale ◽  
Challenge Test ◽  
Psychiatric Emergency ◽  
Significant Response ◽  
Rank Test ◽  
Emergency Setting ◽  
Treatment Protocols ◽  
Signed Rank ◽  
Before And After ◽  
Signed Rank Test

Objective: Catatonia can be life-threatening unless timely identified and treated. Lorazepam’s ubiquitous response has led to its universal acceptance as being the first-line management of catatonia and alludes to catatonia’s neurobiological underpinnings. Lorazepam challenge test (LCT) is widely used to either confirm a catatonia diagnosis or determine lorazepam sensitivity. It has a proposed schedule for administering lorazepam. However, efficacy of recommended LCT doses lack systematic evidence, resulting in variable LCT doses used in clinical and research settings contributing to findings that are challenging to generalize or assist with developing standardized lorazepam treatment protocols for catatonia. Given the same, this study aimed to objectively compare the response between two groups receiving different LCT doses and factors influencing the same. Methods: The 6-month study in a psychiatric emergency setting at a tertiary neuropsychiatric center in India evaluated 57 catatonia patients, before and after administration of single 2 mg ( n = 37; LCT-2) or 4 mg ( n = 20; LCT-4) lorazepam dose, applying Bush Francis Catatonia Rating Scale (BFCRS), Mini International Neuropsychiatric Interview (MINI 5.0) and obtaining sociodemographic, clinical data. Results: No between-group differences (LCT-2 vs LCT-4) for sociodemographic, clinical profiles or BFCRS severity score changes to lorazepam on Mann–Whitney U test were noted. Applying Wilcoxon signed rank test comparing individual sign severity demonstrated response variability, with significant response noted to both doses (stupor, mutism, staring, posturing, withdrawal, ambitendency, automatic obedience) and others selectively to 2 mg (echolalia, rigidity, negativism, mitgehen). Notably, sign resolution (present/absent) only to 2 mg was significant for stupor, mutism, staring, posturing, echolalia, rigidity, negativism and mitgehen. Conclusion: This study suggests 2 mg lorazepam may be an optimal LCT dose, given significant response to most catatonic signs thereby ensuring accurate detection and preventing misinterpretation of response. It offers future studies direction for standardizing lorazepam dosing schedules for catatonia management and exploring neurobiological underpinnings for individual catatonic signs that may be potentially different, given these findings.

Sign in / Sign up

Export Citation Format

Share Document